All Stories

  1. PLGA nanoparticles and soluble Leishmania antigens confer protection in visceral leishmaniasis

    Article • International Journal of Nanomedicine, August 2017, Dove Medical Press

    Evdokia Karagouni, Evita Athanasiou, Maria Agallou, Maritsa Margaroni

  2. Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis

    Article • PLOS One, February 2016, PLOS

    Maria Agallou

  3. Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins

    Article • Frontiers in Immunology, June 2014, Frontiers

    Maria Agallou

  4. In silico prediction of promiscuous Leishmania infantum KMP-11, H1, LeIF, CPA, CPB peptides and experimental validation of eliciting CD4+ and CD8+ T-cell specific responses

    Article • Frontiers in Immunology, January 2013, Frontiers

    Maria Agallou

  5. Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis

    Article • Vaccine, July 2012, Elsevier

    Maria Agallou

  6. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis

    Article • Vaccine, July 2011, Elsevier

    Maria Agallou